Literature DB >> 19752429

Use of Global Visual Acuity Data in a time trade-off approach to calculate the cost utility of cataract surgery.

Van C Lansingh1, Marissa J Carter.   

Abstract

OBJECTIVE: To determine the cost utility of cataract surgery worldwide using visual acuity (VA) outcomes and utility values determined by the time trade-off (TTO) method. DATA SOURCES: Some cost data were taken from a previous search conducted for 1995 to 2006 and we searched MEDLINE and Scopus and Google for more recent data (2006 and 2007). STUDY SELECTION: Articles were identified from the literature using "cataract surgery" in combination with the terms outcome or visual acuity. Additional searches were conducted using individual countries as a term in combination with VA, outcome, or cost. Regression curves were constructed from utility values derived from a TTO study and VA data. Gains in quality-adjusted life-years (QALYs) were calculated based on life expectancy tables from the World Health Organization and discounts of 3% for both cost and benefit. Sensitivity analyses explored the effect of changes in discounting, life expectancy, preoperative VA, and cost. DATA EXTRACTION: If the data were usable, they were kept; otherwise they were discarded. DATA SYNTHESIS: Preoperative VA (logMAR) correlated with increasing gross national income per capita (Pearson correlation coefficient, -0.784; P < .001) and showed that in developing countries preoperative vision is much poorer compared with developed countries. Cost utility data ranged from $3.5 to $834/QALY in developing countries to $159 to $1356/QALY in developed countries. Sensitivity analysis showed that changing life expectancy, VA, and discount rate resulted in moderate changes.
CONCLUSIONS: The TTO approach demonstrates that cataract surgery is extremely cost-effective.

Entities:  

Mesh:

Year:  2009        PMID: 19752429     DOI: 10.1001/archophthalmol.2009.113

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  The Royal College of Ophthalmologists' Cataract Surgery Commissioning Guidance: executive summary.

Authors:  A C Day; R Wormald; S Coronini-Cronberg; R Smith
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

2.  Cost-effectiveness of cataract surgery in Japan.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2011-06-22       Impact factor: 2.447

3.  Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study.

Authors:  Yoshimune Hiratsuka; Masakazu Yamada; Yoko Akune; Akira Murakami; Annabelle A Okada; Hidetoshi Yamashita; Yuichi Ohashi; Naoya Yamagishi; Hiroshi Tamura; Shunichi Fukuhara; Tomoyuki Takura
Journal:  Jpn J Ophthalmol       Date:  2013-04-16       Impact factor: 2.447

4.  Variation of cataract surgery costs in four different graded providers of China.

Authors:  Jiahua Fang; Xinghua Wang; Zhende Lin; Jihua Yan; Ye Yang; Jingbo Li
Journal:  BMC Public Health       Date:  2010-09-09       Impact factor: 3.295

5.  Beyond monetary benefits of restoring sight in Vietnam: Evaluating well-being gains from cataract surgery.

Authors:  Simon Feeny; Alberto Posso; Lachlan McDonald; Truong Thi Kim Chuyen; Son Thanh Tung
Journal:  PLoS One       Date:  2018-02-12       Impact factor: 3.240

6.  Treatment costs of cystoid macular edema among patients following cataract surgery.

Authors:  Jordana K Schmier; David W Covert; Carolyn K Hulme-Lowe; Anmol Mullins; Emmanuel M Mahlis
Journal:  Clin Ophthalmol       Date:  2016-03-16

7.  Cost-Utility Analyses of Cataract Surgery in Advanced Age-Related Macular Degeneration.

Authors:  Yingyan Ma; Jiannan Huang; Bijun Zhu; Qian Sun; Yuyu Miao; Haidong Zou
Journal:  Optom Vis Sci       Date:  2016-02       Impact factor: 1.973

8.  Multicenter Evaluation of Time, Operational, and Economic Efficiencies of a New Preloaded Intraocular Lens Delivery System versus Manual Intraocular Lens Delivery.

Authors:  Javier Mendicute; Lucia Bascarán; Luis Pablo; Cédric Schweitzer; Laurent Velasque; Christine Bouchet; Aldo A Martinez
Journal:  Clin Ophthalmol       Date:  2021-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.